anc Tour de France teams preparing for August start as coronavirus delays race By www.abc.net.au Published On :: Wed, 15 Apr 2020 09:59:24 +1000 Cycling's most famous event may still go ahead this year, despite the French Government banning mass gatherings in the country until at least the middle of July. Full Article Sport Cycling COVID-19
anc Chance for AFLW and other women's leagues to reboot after COVID-19 By www.abc.net.au Published On :: Sat, 18 Apr 2020 10:04:26 +1000 Women's sport, like most things, will look different post COVID-19 — but that isn't necessarily a negative, writes Kim Encel. Full Article Infectious Diseases (Other) Respiratory Diseases COVID-19 Sport Australian Football League
anc Are car rallies possible in the age of social distancing? Targa Australia thinks so By www.abc.net.au Published On :: Tue, 21 Apr 2020 06:00:00 +1000 There might be no crowds at the start and finish lines, and drivers would get Zoom briefings, but Targa Australia says it hopes to still deliver its Far North Queensland tarmac rally in September if some restrictions are lifted. Full Article COVID-19 Motor Sports Business Economics and Finance Tourism Travel and Tourism Events Sport
anc Players who breached social-distancing rules put NRL restart at risk, Federal Sport Minister says By www.abc.net.au Published On :: Wed, 29 Apr 2020 10:22:20 +1000 Federal Minister Richard Colbeck says he hopes sport halted by the coronavirus pandemic can get started again, but warns NRL players' misbehaviour threatens a return of play. Full Article Infectious Diseases (Other) Respiratory Diseases COVID-19 Sport Rugby League NRL
anc The Last Dance dives into the sketchier side of Michael Jordan's legacy By www.abc.net.au Published On :: Tue, 05 May 2020 16:48:33 +1000 Michael Jordan is remembered as the greatest basketball player ever, but memories of his time in the sun often don't extend beyond the hardwood and when they do, it's not always pretty. Full Article Basketball Television Sport
anc NRL players who refuse flu shot can still play 'under compelling circumstances' By www.abc.net.au Published On :: Thu, 07 May 2020 17:33:06 +1000 The NRL announces players who choose not to have the flu vaccination on religious, medical or conscientious grounds will be allowed to train and play, but they must sign a revised waiver. Full Article Infectious Diseases (Other) Respiratory Diseases COVID-19 Sport Rugby League NRL
anc Questions may linger over Michael Jordan and The Last Dance. But just enjoy the show By www.abc.net.au Published On :: Fri, 08 May 2020 06:00:34 +1000 Questions have been raised around the making of the new Michael Jordan documentary, or why it even exists. But maybe we should just enjoy the show, writes Paul Kennedy. Full Article Sport Basketball Documentary Arts and Entertainment
anc Adelaide Crows avoid police sanction over social distancing 'mistake' By www.abc.net.au Published On :: Fri, 08 May 2020 10:51:52 +1000 The Adelaide Crows will be dealt with in an "educative way rather than a punitive way", police say, after players broke coronavirus quarantine guidelines during a training session. Full Article Sport Australian Football League COVID-19 Diseases and Disorders Health
anc Review: Indie drama 'Working Man' veers off course despite strong performance by Peter Gerety By www.latimes.com Published On :: Wed, 6 May 2020 15:15:38 -0400 Veteran character actor Peter Gerety has a meaty role in Richard Jury's "Working Man" even as the movie shifts from quiet dignity into melodrama. Full Article
anc Could a 'controlled avalanche' stop the coronavirus faster, and with fewer deaths? By www.latimes.com Published On :: Sat, 25 Apr 2020 17:21:35 -0400 Israeli scientists say they can mimic the effects of a vaccination campaign if certain people willingly get infected with the coronavirus and recover. Full Article
anc Governors say they'll ease virus restrictions, with an abundance of caution By www.latimes.com Published On :: Sun, 26 Apr 2020 14:50:00 -0400 The governors of Colorado and New York outlined plans to ease pandemic restrictions but stressed they were moving with caution. Full Article
anc Colorado, Tennessee and other states ease coronavirus restrictions; New York cancels presidential primary By www.latimes.com Published On :: Mon, 27 Apr 2020 14:40:07 -0400 Colorado, Montana and Tennessee are among states to reopen amid coronavirus outbreak. Full Article
anc Syrian President Bashar Assad faces rare dissent from a top financial ally, cousin Rami Makhlouf By www.latimes.com Published On :: Fri, 8 May 2020 15:55:07 -0400 Syria's Bashar Assad faces dissent from his rich cousin Rami Makhlouf Full Article
anc Coronavirus: What could a socially-distanced bar look like? By www.bbc.co.uk Published On :: Sat, 09 May 2020 12:51:52 GMT How bars and restaurants could look when coronavirus restrictions are eased. Full Article
anc Stream #WithMe: YouTubers dance, cook and quiz in livestream for NHS By www.bbc.co.uk Published On :: Fri, 01 May 2020 17:37:46 GMT Stars like Saffron Barker, Big Narstie and Yammy take part in a four-hour event to raise money. Full Article
anc The Last Dance: 'I did not anticipate this reaction' By www.bbc.co.uk Published On :: Wed, 06 May 2020 17:18:20 GMT Jason Hehir speaks to the BBC about interviewing Michael Jordan and why the documentary series has had such an impact. Full Article
anc Geneva Healthcare Garners $6,193,845 New Financing Round By www.sandhill.com Published On :: Sat, 29 Oct 2016 06:00:03 +0000 Revolutionizing cardiac device data management Full Article
anc Blackline Systems Lands $146,000,000 New Financing Round By www.sandhill.com Published On :: Sat, 29 Oct 2016 07:00:07 +0000 BlackLine (NASDAQ: BL) is the worlds most trusted solution for Finance Controls & Automation for delivering powerful real-time automation to accounting & finance teams. Full Article
anc Delta ID Obtains $8,964,002 New Financing Round By www.sandhill.com Published On :: Tue, 01 Nov 2016 06:00:02 +0000 Delta ID provides the most convenient authentication solution to secure your digital ID. Full Article
anc Solovis Receives $1,250,000 New Financing By www.sandhill.com Published On :: Tue, 01 Nov 2016 07:00:06 +0000 You’re not just getting great software. We’ve sat in your seat and wished there was a better way, so we built it. We provide a multi-asset class portfolio management and reporting system. Full Article
anc Former Love Island contestant says she's 'glad' the show has been cancelled By www.manchestereveningnews.co.uk Published On :: Mon, 4 May 2020 14:13:08 +0000 Mental health advocate Malin Andersson reacted to the news that the ITV2 dating show has been shelved Full Article Celebs
anc Molly-Mae and Tommy Fury's anger as dozens ignore lockdown rules in Ancoats By www.manchestereveningnews.co.uk Published On :: Fri, 8 May 2020 18:35:23 +0000 The pair shared video of people gathering in the sunshine Full Article Celebs
anc KRPA urges state govt to bring pharmacists under insurance cover on lines of healthcare workers engaged in treating COVID─19 patients By pharmabiz.com Published On :: 20200505080001 Full Article
anc Finance ministry set to extend anti─dumping duty on import of sodium citrate from China By pharmabiz.com Published On :: 20200507080005 Full Article
anc MTaI urges govt to provide relief to medical devices cos to come out of COVID─19─induced financial crisis and logistics bottlenecks By pharmabiz.com Published On :: 20200507080002 Full Article
anc AIOCD urges govt to provide insurance cover to chemists to strengthen fight against COVID─19 By pharmabiz.com Published On :: 20200507080001 Full Article
anc Union health minister calls upon all scientific depts to develop enhanced synergy for better results By pharmabiz.com Published On :: 20200508080001 Full Article
anc Manufacturer forms alliance to cope with the demand for PPE By www.medicalplasticsnews.com Published On :: Tue, 05 May 2020 15:48:04 -0000 Manufacturer and designer, Placon, has introduced the Face Shield Alliance to provide healthcare workers and first responders with adequate Personal Protective Equipment (PPE) during the Covid-19 pandemic. Full Article
anc Huffington Post: Data Exclusivity: Getting the Balance Right By patentlybiotech.wordpress.com Published On :: Tue, 24 May 2011 19:12:55 +0000 Huffington Post: Data Exclusivity: Getting the Balance Right A great article on the downsides of cutting or removing data exclusivity provisions for biologics. The article points out that data protection is needed to enhance safety and create incentives to research and produce new innovative drugs that cost billions of dollars. However, the author argues that the period must be […] Full Article Uncategorized 12 years exclusivity Biologics data exclusivity huffington post incentivizing drug development
anc Crescendo links with CRUK to progress cancer therapy By www.pharmatimes.com Published On :: Tue, 05 May 2020 10:23:22 +0100 The charity's Centre for Drug Development will sponsor and fund a future Phase I clinical trial for CB213 Full Article
anc ICR welcomes new advanced prostate cancer treatment guideline By www.pharmatimes.com Published On :: Wed, 06 May 2020 12:11:18 +0100 NHS England has expanded access to targeted hormone therapies for advanced prostate cancer Full Article
anc E&C Leaders Announce Committee Teleconference Forum on COVID-19 Testing, Contact Tracing and Surveillance on May 8 By energycommerce.house.gov Published On :: Thu, 07 May 2020 00:00:00 -0400 Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Ranking Member Greg Walden (R-OR) today announced that the Full Committee will hold a teleconference forum on Friday, May 8, at 12 pm (EDT) on COVID-19 testing, contact tracing and surveillance. “Our nation cannot effectively combat this terrible pandemic in the weeks and months ahead without significant testing, contact tracing and surveillance,” Pallone and Walden said. “We look forward to hearing from health experts about what actions they believe are necessary to ensure our communities have the resources they need to fight this pandemic and to confidently reopen their local economies.” During the forum, the Committee will hear from three health experts: Andy Slavitt, former Acting Administrator of the Centers for Medicare & Medicaid Services (CMS) from 2015-2017. Mark McClellan, M.D., Ph.D., former Administrator of CMS from 2004-2006 and former Commissioner of the Food and Drug Administration (FDA) from 2002-2004. Avik Roy,Co-founder and President of the Foundation for Research on Equal Opportunity. This forum is open to the press. Credentialed reporters interested in listening to the forum live should RSVP to cj.young@mail.house.gov by 4 pm today, Thursday, May 7. ### Full Article
anc Encouraging Signals for New Cancer Cell Therapy Strategies By xconomy.com Published On :: Wed, 06 May 2020 12:14:46 +0000 Chimeric antigen receptor T-cell therapies have shown remarkable efficacy in leukemia and lymphoma patients who relapsed or were refractory to several prior treatments, but many challenges remain in the cancer cell therapy field. Strategies that may improve upon first-generation therapies were presented during the American Association for Cancer Research virtual meeting with encouraging early activity, […] Full Article Boston blog main Boston top stories Boulder/Denver blog main Boulder/Denver top stories Detroit blog main Detroit top stories Europe blog main Europe top stories Indiana blog main Indiana top stories National National blog main New York blog main New York top stories Raleigh-Durham blog main Raleigh-Durham top stories San Diego blog main San Diego top stories San Francisco blog main San Francisco top stories Seattle blog main Seattle top stories Texas blog main Texas top stories Wisconsin blog main Wisconsin top stories Acute Lymphoblastic Leukemia American Association for Cancer Research Biotech cancer Cancer Drugs CAR-T immunotherapy clinical trials FDA Gilead Sciences Gracell Biotechnologies Immunotherapy Iovance Biotherapeutics Kite Pharma Leukemia Life Sciences Melanoma National Cancer Institute Non-Small Cell Lung Cancer Roche University of California at Los Angeles Xinin Wang Yvonne Chen
anc Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation By xconomy.com Published On :: Thu, 07 May 2020 01:46:05 +0000 As cancer research reveals the genetic basis of the disease, pharmaceutical companies are pursuing targeted therapies that address certain groups of patients. One such drug from Novartis won FDA approval Wednesday, making it the first therapy cleared by the agency to treat patients whose non-small cell lung cancer (NSCLC) carries a certain genetic mutation. The […] Full Article National National blog main American Cancer Society Biotech cancer Cancer Drugs clinical trials companion diagnostic FDA Foundation Medicine Incyte kinase inhibitor Life Sciences myelofibrosis Novartis ruxolitinib
anc Ayala’s IPO Raises $55M to Test Two Former Bristol Myers Cancer Drugs By xconomy.com Published On :: Fri, 08 May 2020 13:05:23 +0000 Ayala Pharmaceuticals has two clinical-stage cancer drugs licensed from Bristol Myers Squibb. Now it has $55 million to take those drugs further than the pharmaceutical giant did. On Thursday evening, Ayala priced its IPO, which consisted of 3.7 million shares sold for $15 each. That price was the midpoint of the targeted $14 to $16 […] Full Article National National blog main New York blog main New York top stories Acute Lymphoblastic Leukemia Adenoid Cystic Carcinoma Ayala Pharmaceuticals B-cell maturation antigen Biotech Bristol-myers Squibb clinical trials deals Desmoid tumors FDA investing IPO Israel Biotech Fund Life Sciences Novartis Pfizer SpringWorks Therapeutics triple-negative breast cancer
anc Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug By xconomy.com Published On :: Sat, 09 May 2020 02:33:40 +0000 Eil Lilly received accelerated FDA approval Friday for a drug that treats advanced cancers carrying a certain genetic signature. It’s the latest targeted cancer therapy to pass the regulatory bar and the first that addresses tumors characterized by aberrations in one particular gene. The gene in question, RET, produces a protein involved in cell signaling. […] Full Article Boston blog main Boston top stories Indiana Indiana blog main Indiana top stories National blog main National top stories New York blog main New York top stories Biotech Blueprint Medicines cancer Cancer Drugs clinical trials Eli Lilly FDA Life Sciences medullary thyroid cancer Non-Small Cell Lung Cancer Novartis pralsetinib selpercatinib Thyroid Cancer
anc Former Ergomed CEO appointed as Midatech’s Chief Financial Officer By www.pharmafile.com Published On :: Wed, 11 Sep 2019 13:43:35 +0000 Immunotherapy-focused pharmaceutical company Midatech Pharma has appointed Stephen Stamp as Chief Financial Officer (CFO) with immediate effect. He will be replacing Nick Robbins-Cherry, who has stepped down after five years since joining in 2014. Robbins will nevertheless remain at Midatech until October to facilitate Stamp’s handover in an orderly fashion. Stamp has most recently served as CEO of pharmaceutical firm Ergomed for two years, stepping down in January citing health reasons. Prior to this he was CFO at Ergomed for a year beginning in 2016. read more Full Article ergomed midatech Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
anc Alligator Bioscience hires Chief Financial Officer in interim capacity By www.pharmafile.com Published On :: Mon, 09 Mar 2020 17:21:44 +0000 Andreas Johannesson has been announced as Alligator Bioscience’s new interim Chief Financial Officer (CFO), replacing ex-CFO Per-Olof Schrewelius who it was previously confirmed will no longer serve the company. Johannesson’s career has spanned 15 years in the consumer goods sector, with him managing the finances of firms including TeamOlmed, Stenqvist, Fitness23Seven and Haldex. He spent a further nine years of his career as a strategic consultant with a focus on consumer goods, five of which were spent at global consulting firm McKinsey & Company. read more Full Article Alligator Bioscience pharma Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
anc Genmab announces newly-created Chief Financial Officer appointment By www.pharmafile.com Published On :: Mon, 16 Mar 2020 16:43:46 +0000 Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named Anthony Mancini to the post. In this new role, he will oversee the company’s commercial strategies, including corporate development, business development and information technology functions read more Full Article Genmab pharma Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
anc At Joe Biden’s Urging, Airbnb, WeWork, And Others Commit To Help Cancer Patients By www.forbes.com Published On :: Fri, 21 Sep 2018 13:00:00 +0000 The companies are committing to find ways to use their businesses to help patients with cancer. Full Article byline=Matthew Herper
anc Three Things to Look for in a Patient Assistance Program By feeds.feedblitz.com Published On :: Fri, 20 Mar 2020 11:30:00 +0000 Today’s guest post comes from Rob Brown, Vice President and General Manager of RxCrossroads by McKesson and Biologics by McKesson.Rob discusses the importance of access, adherence, and affordability for specialty therapy patients who are uninsured, underinsured, or low-income. He describes three criteria companies should use to evaluate patient assistance program solutions.Click here to learn more about program pharmacy solutions for biopharma from RxCrossroads by McKesson.Read on for Rob’s insights.Read more » Full Article Guest Post Sponsored Post
anc What Is Payer Intelligence—And How Can It Be Combined With Technology to Enhance Patient Access? By feeds.feedblitz.com Published On :: Fri, 17 Apr 2020 11:00:00 +0000 Today’s guest post comes from Scott Dulitz, Chief Strategy Officer at TrialCard. Scott discusses how combining payer intelligence with market-leading technology can enhance patient access.TrialCard recently acquired Policy Reporter, a healthcare software solutions company that provides payer intelligence to the biopharmaceutical, medical device, and diagnostics industries. To learn more, schedule a demo of Policy Reporter or contact Scott (scott.dulitz@trialcard.com).You can also register for Trialcard’s upcoming webinar: Leveraging Payer Intelligence in Patient Service Programs.Read on for Scott’s insights.Read more » Full Article Guest Post Sponsored Post
anc Early Detection: A New Front in the War on Cancer By blogs.scientificamerican.com Published On :: Wed, 06 May 2020 11:00:00 GMT Blood tests that find malignancies before they spread could transform our approach to treatment -- Read more on ScientificAmerican.com Full Article Health Medicine
anc Heat and Humidity Are Already Reaching the Limits of Human Tolerance By www.scientificamerican.com Published On :: Fri, 08 May 2020 18:00:00 GMT Events with extreme temperatures and humidity are occurring twice as often now as they were 40 years ago -- Read more on ScientificAmerican.com Full Article Health Public Health The Body Sustainability Climate Environment
anc John Ratliff of Covance Elected 2018 ACRO Chairman By www.acrohealth.org Published On :: Thu, 25 Jan 2018 21:33:17 +0000 WASHINGTON–(BUSINESS WIRE)–The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected John Ratliff, CEO of Covance Drug... Full Article News Press Releases
anc Advancing the Adoption of Risk-Based Monitoring Strategies in Clinical Trials By www.acrohealth.org Published On :: Fri, 16 Aug 2019 16:01:14 +0000 On July 17, 2019, under cooperative agreement with the FDA, the Duke-Margolis Center for Health Policy (Duke Margolis) held a public workshop. The event, titled Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations, aimed to identify opportunities to improve Risk Based Monitoring (RBM) implementation and solicit stakeholder input on the challenges, barriers, and enablers that impact the successful adoption of RBM. Full Article News FDA RBM Risk Based Montoring
anc ACRO hosts Congressional Briefing on clinical research advancements By www.acrohealth.org Published On :: Thu, 24 Oct 2019 19:12:32 +0000 On Wednesday, October 23, 2019, ACRO hosted a Congressional Briefing on Capitol Hill. With the help of the Congressional Research & Development... Full Article News
anc The world needs a coronavirus vaccine. But it will take time | Patrick Vallance By www.theguardian.com Published On :: 2020-04-19T14:33:51Z Any vaccine has to work, but it also has to be safe. Making it happen is one of the government’s biggest priorities• Patrick Vallance is the UK government chief scientific adviserCoronavirus – latest updatesSee all our coronavirus coverageCovid-19 has made fundamental and long-lasting changes to the way we live our lives, not just in the UK, but across the world.As we continue with social-distancing measures and deal with the most immediate issue of reducing the number of cases to protect the NHS and save lives, and keeping R, which is the average infection rate per person, below one, we also need to progress ways to tackle the disease in the longer term.The vaccines taskforce will be working in lockstep with the public and private sector Related: New UK taskforce to help develop and roll out coronavirus vaccine Continue reading... Full Article Coronavirus outbreak Pharmaceuticals industry Science UK news Drugs Vaccines and immunisation
anc South Korean researchers start testing pancreatitis drug in COVID-19 patients By www.pharmafile.com Published On :: Tue, 28 Apr 2020 10:19:05 +0000 The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 patients. Full Article coronavirus COVID-19 Pancreas Pancreatitis Manufacturing and Production
anc Phase 3 Libtayo monotherapy trial halted early due to strong benefit in advanced non-small cell lung cancer By www.pharmafile.com Published On :: Wed, 29 Apr 2020 11:49:31 +0000 A Phase 3 study of Sanofi and Regeneron’s Libtayo (cemiplimab) as a monotherapy for advanced or metastatic non-small cell lung cancer (NSCLC) has been stopped early after showing strong overall survival benefit, it has emerged. Full Article cancer Libtayo lung cancer Regeneron Research and Development Sanofi